Search
for
Sort by
Research 121–150 of 1000+
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- TREMendous Macrophages Inhibit Hair Growth
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Targeted immunotherapy for hair regrowth and regeneration
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Novedades terapéuticas en tricología
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report